Anterix Inc. (NASDAQ:ATEX) Shares Sold by Garnet Equity Capital Holdings Inc.

Garnet Equity Capital Holdings Inc. trimmed its stake in Anterix Inc. (NASDAQ:ATEX) by 36.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 158,702 shares of the company’s stock after selling 92,000 shares during the quarter. Anterix makes up 1.6% of Garnet Equity Capital Holdings Inc.’s portfolio, making the stock its 11th biggest holding. Garnet Equity Capital Holdings Inc.’s holdings in Anterix were worth $5,288,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Kirr Marbach & Co. LLC IN boosted its stake in shares of Anterix by 54.2% during the 4th quarter. Kirr Marbach & Co. LLC IN now owns 97,985 shares of the company’s stock worth $3,265,000 after purchasing an additional 34,425 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Anterix by 1.4% during the third quarter. Vanguard Group Inc. now owns 831,320 shares of the company’s stock valued at $26,087,000 after buying an additional 11,678 shares during the period. GSA Capital Partners LLP acquired a new stake in Anterix during the third quarter worth approximately $687,000. Luminus Management LLC grew its stake in Anterix by 6.0% in the 3rd quarter. Luminus Management LLC now owns 115,000 shares of the company’s stock worth $3,609,000 after acquiring an additional 6,550 shares during the period. Finally, Tower Research Capital LLC TRC grew its stake in Anterix by 1,843.5% in the 3rd quarter. Tower Research Capital LLC TRC now owns 11,700 shares of the company’s stock worth $367,000 after acquiring an additional 11,098 shares during the period. 87.67% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ATEX has been the subject of a number of research analyst reports. TheStreet raised shares of Anterix from a “d+” rating to a “c-” rating in a research note on Wednesday, February 28th. B. Riley restated a “buy” rating and issued a $75.00 target price on shares of Anterix in a report on Friday, February 16th.

Anterix Price Performance

NASDAQ:ATEX traded up $0.17 during mid-day trading on Thursday, reaching $32.17. The stock had a trading volume of 158,092 shares, compared to its average volume of 112,601. The company has a market capitalization of $595.79 million, a price-to-earnings ratio of 38.10 and a beta of 0.67. Anterix Inc. has a 1-year low of $27.20 and a 1-year high of $40.45. The stock’s 50 day simple moving average is $34.24 and its two-hundred day simple moving average is $32.96.

Anterix (NASDAQ:ATEX) last issued its earnings results on Wednesday, February 14th. The company reported ($0.55) EPS for the quarter, topping the consensus estimate of ($0.61) by $0.06. The company had revenue of $1.27 million during the quarter, compared to analyst estimates of $1.20 million. Anterix had a negative return on equity of 17.22% and a net margin of 447.16%. Sell-side analysts anticipate that Anterix Inc. will post -0.23 EPS for the current fiscal year.

Anterix Profile

Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.